Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe history log now lists a new revision version v3.5.0 and the deletion of v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page history now includes a new revision entry v3.4.2, and the older revision entry v3.4.1 as well as a government-funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check50 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding. Updated the system revision to v3.4.1 and removed the previous revision v3.4.0.SummaryDifference0.3%

- Check57 days agoChange DetectedUI updates to the history page include a 'Show glossary' option and color-coded change indicators with explanatory text, and the footer revision tag updates to Revision: v3.4.0; the 'No FEAR Act data' item is removed.SummaryDifference0.4%

- Check71 days agoChange DetectedRevision: v3.3.4 is now the latest update, replacing v3.3.3, and appears to be a minor site revision with no visible impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.